Select or drop a image or 3D model here to search.
We support JPG, JPEG, PNG, GIF, WEBP, GLB, OBJ, STL, FBX. More formats will be added in the future.
Asset Overview
Nintedanib is a drug indicated for the treatment of idiopathic pulmonary fibrosis (IPF) that targets multiple receptor tyrosine kinases (RTKs) and non-receptor tyrosine kinases (nRTKs). Nintedanib inhibits the following RTKs: platelet-derived growth factor receptor (PDGFR) ? and ?, fibroblast growth factor receptor (FGFR) 1-3, vascular endothelial growth factor receptor (VEGFR) 1-3, and Fms-like tyrosine kinase-3 (FLT3). Among them, FGFR, PDGFR, and VEGFR have been implicated in IPF pathogenesis.
[Read more](https://3dprint.nih.gov/discover/3dpx-008281)
